Skip to main content
SpringerLink
Log in

Placebos and controlled trials under attack

  • Editorial
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Burkhardt, R., Kienle, G.: Controlled clinical trials and medical ethics. Lancet1978/II, 1356–1359

    Google Scholar 

  2. Emotion and Empiricism. (Editorial) Brit. Med. J.1979/I, 288–289

  3. Controlled Trials: Planned Deceptions? (Editorial) Lancet1979/I, 534–535

  4. Freiman, J. A., Chalmers, T. C., Smith, H. Jr., Kuebler, R. R.: The importance of beta, the Type II error and sample size in the design and interpretation of the randomized control trial. N. Engl. J. Med.299, 690–694 (1978)

    Google Scholar 

  5. Lasagna, L.: A plea for the “naturalistic” study of medicine. (Editorial) Eur. J. Clin. Pharmacol.7, 153 (1974)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology and Toxicology, University of Rochester School of Medicine, 14642, Rochester, NY, USA

    L. Lasagna

Authors
  1. L. Lasagna
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lasagna, L. Placebos and controlled trials under attack. Eur J Clin Pharmacol 15, 373–374 (1979). https://doi.org/10.1007/BF00561733

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00561733

Search

Navigation